Short‐term echocardiographic evaluation by global longitudinal strain in patients with heart failure treated with sacubitril/valsartan

Short‐term echocardiographic evaluation by global longitudinal strain in patients with heart failure treated with sacubitril/valsartan

Abstract Aims The angiotensin receptor neprilysin inhibitor (ARNI) sacubitril/valsartan reduces mortality and hospitalizations in patients with heart failure and reduced ejection fraction (HFrEF). Favourable effects on haemodynamic and functional parameters have been observed in patients with HFrEF...

Full description

Bibliographic Details
Main Authors: Simone Mazzetti, Chiara Scifo, Raffaele Abete, Davide Margonato, Margherita Chioffi, Jessica Rossi, Matteo Pisani, Giovanni Passafaro, Massimiliano Grillo, Daniele Poggio, Andrea Mortara
Format: Article
Language:English
Published: Wiley 2020-06-01
Series:ESC Heart Failure
Subjects:
Heart failure
Heart failure with reduced ejection fraction
Angiotensin receptor neprilysin inhibitor
Global longitudinal strain
Renin–angiotensin–aldosterone system
Neprilysin
Online Access:https://doi.org/10.1002/ehf2.12656

Internet

https://doi.org/10.1002/ehf2.12656

Similar Items